AzTrials
AzTrials

Traumatic Brain InjuryNCT06966713

Predict Severe Traumatic Brain Injury

An observational study of Traumatic Brain Injury, run by University of Chicago at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Severe traumatic brain injury (TBI) is associated with a 20-30% mortality rate and significant disability among most survivors. The Centers for Disease Control and Prevention (CDC) estimate that 2% of the U.S. population lives with disabilities directly attributable to TBI, with annual costs exceeding $76.5 billion. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Traumatic Brain Injury
How many people
120 participants
Where
2 sitesUnited States
Study dates
20 Feb 2023to 31 Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Traumatic brain injury patients admitted to University of Chicago or Baylor College of Medicine

Who may be able to join

  • Patients age >18 years old
  • Severe TBI, determined by initial Glasgow Coma Scale (GCS) score after resuscitation and without the influence of paralytics or sedation, (GCS score ≤8, motor score ≤5, not following commands)
  • The clinical need for ICP and/or PbtO2 monitoring according to the BTF guidelines
  • Be able to enroll during the course of their stay in the ICU

Who cannot join

  • Neurological exam suggesting imminent brain death (bilateral, fixed and dilated pupils) or questionable accuracy of the neurologic exam (high blood alcohol level and/or seizure activity < 30 minutes of exam)
  • Evidence of pregnancy (urine or blood test)
  • Placement of intracranial monitoring is contraindicated (e.g., uncorrected coagulopathy, depressed skull fracture)
  • Inability to obtain informed consent from legal authorized representative (LAR) prior to research procedures
  • Participation in another interventional clinical trial (coenrollment with the BOOST3 (CIRB19-0228) trial is allowed*)
  • Prisoner

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States2 sites, 2 recruiting
  • University of Chicago

    Chicago, Illinois, 60637

    Farima Fakhri, MD, 773-702-1220, farima.fakhri@bsd.uchicago.edu

    Christos Lazaridis, MD

    Recruiting
  • Baylor college of medicine

    Houston, Texas, 77030

    Jose Marcelo Rizzoli Mayans, 832-360-7292, jose.rizzolimayans@bcm.edu

    Jovany Cruz Navarro, MD

    Recruiting

Other trials in United States

About this study

Official title: Prediction and Prevention of Intracranial Hypertension and Tissue Hypoxia in Severe Traumatic Brain Injury

Severe traumatic brain injury (TBI) is associated with a 20-30% mortality rate and significant disability among most survivors. The Centers for Disease Control and Prevention (CDC) estimate that 2% of the U.S. population lives with disabilities directly attributable to TBI, with annual costs exceeding $76.5 billion.

Current treatments are largely ineffective because they are instituted after irreversible damage has already occurred. By the time intracranial pressure (ICP) increases or brain tissue oxygen tension (PbtO2) decreases to harmful levels, it is often too late to reverse or repair the damage. A computerized method has been developed that can predict these injurious events ahead of time, allowing clinicians to intervene before further damage occurs. The goal of this proposal is to test these predictions in real time.

Read more

The first phase of the project (Year 1) involves setting up the informatics infrastructure, with no patient interaction. In the second phase (Year 2), subjects, through surrogate decision-makers, will be enrolled in an observational study where data on intracranial pressure and brain tissue oxygen tension will be collected, and the prediction algorithm will be tested for accuracy. Clinical management will follow standard care protocols, and no additional interventions will be performed.

Approximately 120 individuals will participate in this study at the University of Chicago and Ben Taub General Hospital in Houston. Data collected will include both the electronic medical record and data from bedside intensive care unit monitors. The electronic medical record includes demographic information, injury characteristics, laboratory values, and imaging data, while the intensive care unit monitor provides real-time vital signs such as intracranial pressure, brain tissue oxygen tension, and mean arterial pressure. These data will be securely stored in a research computer database.

Efforts will be made to contact subjects or their caretakers at 6 months to follow up on recovery. This research aims to improve patient outcomes by providing predictions of further brain injury, with the potential for future interventions to prevent permanent brain damage.

Read the detailed description

Recently, the investigators achieved prediction of episodes of intracranial hypertension (ICH) and brain tissue hypoxia (BTH) 30 minutes to several hours in advance of overt deterioration using intuitive and simple models whose inputs include recent intracranial pressure (ICP) or partial brain tissue oxygen tension (PbtO2) values, the time since the last crisis, and the fraction of time spent with high/low ICP or PbtO2, respectively. A retrospective study was conducted based on prospectively collected physiologic data, and machine-learning-based algorithms were developed to recognize physiologic patterns in severe traumatic brain injury (TBI) patients that occur in advance of ICP and PbtO2 crises. These events were defined as ICP ≥ 20 mmHg lasting at least 15 minutes and PbtO2 values < 10 mmHg for at least 10 minutes, respectively. The physiologic data preceding each crisis event were used to identify precursors associated with crisis onset. Further investigation was conducted to assess how model performance changed as the prediction time increased, providing an estimate of the clinical timescale of crisis precursors. Multivariate classification models were applied to recorded data in 30-minute epochs of time to predict crises between 15 and 360 minutes in the future. The cohort consisted of 817 TBI patients admitted to the neurocritical care unit at Ben Taub Hospital (Houston, Texas). The algorithm predicted the onset of ICP crises with 30 minutes advance warning with an area under the curve (AUC) of 0.86, in independent data, using only ICP measurements and time since last crisis. An analogous algorithm predicted the onset of PbtO2 crises with 30 minutes advance warning with an AUC of 0.91.

This phase seeks to study prospectively the performance of algorithms and the alerting system for the prediction of intracranial hypertension and brain hypoxia crises. The virtual monitor (VM) will be applied to all consecutive severe traumatic brain injury (TBI) patients. Alerts will be generated by the algorithms and sent to study team members. Detailed annotation of clinical interventions and events will be collected; attending physicians and all clinical providers will be blinded to the presence of the monitor and to the alerts. This will allow for the comparison of prospectively collected crisis alerts with actual events of intracranial hypertension and brain tissue hypoxia that follow them (or not). The goal is to establish the sensitivity of the prediction algorithms as defined by the rate of true positive (TP) predictions (TP predictions are the ones accompanied by actual crises of ICP and/or PbtO2 within 30 minutes of the generated alert). Instances of actual crisis episodes that have not been preceded by an alert will also be collected and analyzed. This phase of the study will be run in 4 cycles, each consisting of 2 months of data collection, followed by 1 month of system improvements. Technical improvements to the system (such as adjusting the alerting threshold, user interface features, etc.) will be made at the end of each cycle, based on feedback provided by the study team from the previous 2 months of data collection.

This phase involves clinical management per local neurocritical care unit standards and as per Brain Trauma Foundation (BTF) guidelines (see below baseline standard assessments, and Table 1 for tiered approaches to violations of ICP and PbtO2 thresholds). Alerts will only be available to study personnel (study physician members not directly involved in patient care, and study coordinators) for the purposes of evaluating real-time applied accuracy of the algorithm and alerting system.

Each year in the United States, about 2 million people sustain traumatic brain injury (TBI), and of these, 500,000 require hospital care. Severe traumatic brain injury (TBI) is associated with 20-30% mortality and significant disability among most survivors. The Centers for Disease Control and Prevention (CDC) estimate that 2% of the U.S. population lives with disabilities directly attributable to TBI, with annual costs exceeding $76.5 billion.

Largely, current treatments are ineffective due to being instituted at a time when irreversible damage has already occurred. By the time it is recognized that the traumatized brain is being further injured due to high pressure or lack of oxygen, it is too late to reverse or repair the insult. A computerized method is proposed to recognize further brain injury before it occurs. The ability to predict these events ahead of time will allow clinicians to prepare and prevent these episodes before they cause permanent brain damage.

The investigators have already developed a method that can provide accurate prediction of these injurious events. This proposal aims to test predictions in real time. The patients to benefit from this project include individuals who suffer all kinds of severe trauma to the brain. This research promises to improve the outcome of these patients by providing predictions of further brain injury and, in the future, a way to act upon them to prevent permanent brain damage.

This proposal is divided into two yearly phases. The first year focuses on establishing the capability of extracting and analyzing data from bedside monitors in the intensive care unit (ICU). The second year will test in real time the accuracy of the predictions.

The first part of the project (Year 1) does not involve any patient or subject interaction. This year is solely for informatics infrastructure setup.

In the second part of the project (Year 2), subjects (via their surrogate decision-makers) will be asked to be enrolled in an observational study where data on ICP and PbtO2 are collected, and the prediction algorithm is tested for accuracy and performance. During this phase, clinical management will be per standard of care, and no additional interventions will be performed. This phase will be conducted under this protocol and a dedicated consent form (consent for Phase 2; attached at the end).

Efforts will be made to contact the subject or their caretakers at 6 months for follow-up on recovery.

Approximately 120 individuals will take part in this study at the University of Chicago and Ben Taub General Hospital in Houston.

This project utilizes a computerized method to predict ongoing and future brain injury. The data to be collected includes two sources: the first is the electronic medical record (EMR), which includes demographic information, characteristics of the injury, laboratory values, and data from imaging. The second source is directly from the bedside ICU monitor, including vital signs such as intracranial pressure (ICP), brain tissue oxygen (PbtO2), and mean arterial pressure (MAP). All data will be securely stored in a research computer database.

Expanded Acronyms/Abbreviations:

  • Intracranial Hypertension (ICH)
  • Brain Tissue Hypoxia (BTH)
  • Intracranial Pressure (ICP)
  • Partial Brain Tissue Oxygen Tension (PbtO2)
  • Traumatic Brain Injury (TBI)
  • Area Under the Curve (AUC)
  • True Positive (TP)
  • Virtual Monitor (VM)
  • Brain Trauma Foundation (BTF)
  • Centers for Disease Control and Prevention (CDC)
  • Intensive Care Unit (ICU)
  • Electronic Medical Record (EMR)
  • Mean Arterial Pressure (MAP)
Medical subject headings
Brain Injuries, Traumatic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modified Rankin Scale (mRS)

    The mRS assesses global disability, ranging from 0 (no symptoms) to 6 (death), with higher scores indicating worse outcomes.

    Measured: 3, 6, and 12 months post-discharge

  2. Rivermead Post-Concussion Symptoms Questionnaire (RPQ)

    The RPQ evaluates post-concussion symptoms across physical, cognitive, and emotional domains. Higher scores indicate greater symptom burden.

    Measured: 3, 6, and 12 months post-discharge

  3. Glasgow Outcome Scale-Extended (GOSE)

    The GOSE assesses functional outcome after TBI, ranging from 1 (death) to 8 (upper good recovery). Higher scores indicate better recovery.

    Measured: 3, 6, and 12 months post-discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2025
  2. Study start20 Feb 2023
  3. Primary completion13 Jul 2026 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06966713
Sponsor's protocol ID
IRB22-0871
Other IDs
W81XWH22C0058
Status last verified
Oct 2025
First submitted
24 Feb 2025
Last updated
10 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Traumatic Brain Injury, run by University of Chicago at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Farima Fakhri, MD (7737021220, Farima.Fakhri@bsd.uchicago.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modified Rankin Scale (mRS) (time frame: 3, 6, and 12 months post-discharge). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in